Foundation for innovation
in Cardiometabolism and Nutrition

Hepatology

Hepatology

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network